"NSTK:ONLY SPECULATORS WERE BUYING YESTERDAY. NIBBLING WITH WHAT IS LEFT OF AN $18 DOLLAR A SHARE COMPANY. CREAME RISES TO THE TOP AND NSTK WILL CONTINUE ITS DECLINE TO FORM NEW LOWS & IT STILL IS HEADED TO $1.00 BID. OF COURSE NSTK IS TRYING TO CHANGE ITS NAME AND START A NEW LIFE IN THE MEANTIME."

"NSTK:RIGHT NOW THE FORCES ARE AGAINST THEM FORM ALL SIDES! http://quote.barchart.com/texadv.asp?sym=NSTK HOPE-BLEAK FDA APPROVAL-JUST CHECK THE BIG PHARMA'S AND SEE HOW MANY DECLINES THERE WERE IN THE PAST 6 MONTHS. BETTER STILL LOOK AT NSTK'S PAST RECORD WITH PARTNERS&FDA. CAN'T CHANGE COMPANY BUT CAN CHANGE COMPANIES NAME&MANAGEMENT. ON COURSE FOR $1.00 BID! NO WONDER WHY THE CHIEF FINANCIAL OFFICER RESIGNED. AND TAUNYA SELL GIVES THIS BATTERED COMPANY 4 RED STARS!"

"MAY12-NSTK-ON COURSE TO A $1.00 BID AS I'VE BEEN SAYING FOR AWHILE NOW. I HAVE BEEN PRECISELY CORRECT SINCE SEPTEMBER 2007. CONFIRM ON MSN-MONEY CENTRAL! CONFIRM ON PREDICT WALL STREET, WHERE THE AVERAGE NOVICE INVESTOR CAN EARN HIS OR HER STAR RATINGS BY BEING CONSISTENTLY RIGHT. THE VOPICE OF THE INVESTOR! THANK YOU PREDICT WALL STREET FOR THE OPPORTUNITY!"

"NSTK-Like the TITANIC nstk has been sinking since Novemer 2007. Yet amazingly research firms that follow nstk have not adjusted their high target prices to date. On March 19, Taunya Sell of RAGEN MACKENZIE, A DIVISION OF WELLS FARGO GAVE NSTK A 4 STAR RATING. TO DATE STOC HAS DROPPED 47%. NOW YESTERDAY, ONCE AGAIN A NEW 4 STAR RATING BY TAUNYS SELL OF RAGEN MACKENZIE. I ASK YOU WHY? HOW FOOLISH DOES RAGEN MACKENZIE WANT TO LOOK, BACKING A NEW 4 STAR RANKING BY AN EMPLOYEE WHO ALREADY STUBBED H"

"May 9-earnings loss higher than 1 year ago. Revenue lower than 1 year ago. Earnings reports & Revenue reports for the rest of 2008 will be worse. I believe the rug will be pulled out from under investors shortly. On course for a $1.00 Bid soon!"